These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3446040)

  • 1. Protective effects of indeloxazine hydrochloride on cerebral ischemia in animals.
    Yamamoto M; Shimizu M; Sakamoto N; Ohtomo H; Kogure K
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):16-24. PubMed ID: 3446040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of indeloxazine hydrochloride on behavioral and biochemical changes in the chronic phase of focal cerebral ischemia in rats.
    Shimizu-Sasamata M; Yamamoto M; Okada M; Yamaguchi T; Tamura A
    Arch Int Pharmacodyn Ther; 1991; 314():74-89. PubMed ID: 1824190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hypoxic and anti-ischemic actions of indeloxazine hydrochloride and its optical isomers: possible involvement of cerebral energy metabolism.
    Shimizu-Sasamata M; Terai M; Harada M; Yamamoto M
    Arch Int Pharmacodyn Ther; 1993; 324():33-46. PubMed ID: 8297184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of indeloxazine hydrochloride on brain energy and glucose metabolism in the four-vessel occlusion rat model].
    Sakamoto N; Ohtomo H; Kogure K
    No To Shinkei; 1986 Apr; 38(4):387-91. PubMed ID: 3718783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of indeloxazine, a new cerebral activator, on brain functions distinct from other cerebral metabolic enhancers.
    Yamamoto M; Kawabata S; Shimizu M
    Neuropharmacology; 1989 Dec; 28(12):1291-7. PubMed ID: 2615913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral activating properties of indeloxazine hydrochloride.
    Yamamoto M; Shimizu M
    Neuropharmacology; 1987 Jul; 26(7A):761-70. PubMed ID: 3627384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of indeloxazine hydrochloride (YM-08054) on anoxia.
    Yamamoto M; Shimizu M
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):272-81. PubMed ID: 3592867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indeloxazine hydrochloride, a cerebral activator, on passive avoidance learning impaired by disruption of cholinergic transmission in rats.
    Yamamoto M; Ooyama M; Ozawa Y; Okada M; Tada S; Yamaguchi T; Endo H
    Neuropharmacology; 1993 Jul; 32(7):695-701. PubMed ID: 8395664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indeloxazine hydrochloride on cognitive disturbance in cycloheximide-treated mice.
    Yamamoto M; Shimizu M
    J Pharm Pharmacol; 1989 Apr; 41(4):284-6. PubMed ID: 2568476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced depletion of brain acetylcholine levels in gerbils.
    Ogawa N; Haba K; Yoshikawa H; Ono T; Mizukawa K
    Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):285-8. PubMed ID: 3187197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of bifemelane hydrochloride and indeloxazine hydrochloride on scopolamine hydrobromide-induced impairment in radial maze performance.
    Ogawa N; Haba K; Sora YH; Higashida A; Sato H; Ogawa S
    Clin Ther; 1988; 10(6):704-11. PubMed ID: 3219685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effects of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (bifemelane) on acutely induced cerebral ischemia in Mongolian gerbils and spontaneously hypertensive rats (SHR)].
    Fujishima M; Ishitsuka T; Omae T
    No To Shinkei; 1984 Oct; 36(10):999-1004. PubMed ID: 6518131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of indeloxazine hydrochloride on passive avoidance behavior of senescence-accelerated mice.
    Yamamoto M; Iwai A; Kawabata S; Ozawa Y; Shimizu M
    Eur J Pharmacol; 1989 Jul; 166(2):345-8. PubMed ID: 2792199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lisuride hydrogen maleate on ischemia-induced depletion of brain acetylcholine levels in gerbils.
    Ogawa N; Haba K; Yoshikawa H; Kawata M; Sato H
    Clin Ther; 1989; 11(2):241-6. PubMed ID: 2736570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral vasodilators potentiate the anti-anoxic activity of indeloxazine hydrochloride, a new cerebral activator.
    Yamamoto M; Shimizu M; Kawabata S
    Neuropharmacology; 1989 Mar; 28(3):313-7. PubMed ID: 2725854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indeloxazine hydrochloride improves impairment of passive avoidance performance after fluid percussion brain injury in rats.
    Yamaguchi T; Ozawa Y; Suzuki M; Yamamoto M; Nakamura T; Yamaura A
    Neuropharmacology; 1996 Mar; 35(3):329-36. PubMed ID: 8783208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats.
    Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S
    Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced changes in brain monoamines and their metabolites in gerbils.
    Haba K; Ogawa N; Asanuma M; Hirata H; Mori A
    J Neural Transm Gen Sect; 1992; 88(3):187-98. PubMed ID: 1384558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of VA-045 on disturbance in consciousness in experimental animal models.
    Okuyama S; Imagawa Y; Ogawa S; Saito Y; Araki H; Otomo S; Sakagawa T; Yamada S; Shima K
    Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):91-100. PubMed ID: 8272576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of the novel anti-ischemic agent 2-(4-(p-fluorobenzoyl)-piperidin-1-yl)-2'-acetonaphthone hydrochloride against ischemia-induced impairment of the passive avoidance response in gerbils.
    Ueno M; Nakazawa T; Mihara M; Kaneko T; Yamatsu K
    Arzneimittelforschung; 1990 Dec; 40(12):1292-4. PubMed ID: 2095125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.